Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - marek’s disease virus, live, strain cvi-988 (rispens) - lyophilisat zur herstellung einer injektionssuspension - marek’s disease virus, live, strain cvi-988 (rispens) - avian herpes virus (marek's disease) - geflügel

Europäische Union - Deutsch - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - hähnchen - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international - marek’s disease virus, live, strain cvi-988 (rispens) - konzentrat und lösungsmittel zur herstellung einer injektionssuspension - marek’s disease virus, live, strain cvi-988 (rispens) - avian herpes virus (marek's disease) - geflügel

Europäische Union - Deutsch - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologische für aves - hähnchen - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - die türkei herpes-virus; zellassoziiertes lebendes rekombinantes virus der marekschen krankheit (md) - konzentrat und lösungsmittel zur herstellung einer injektionssuspension - die türkei herpes-virus ; zellassoziiertes lebendes rekombinantes virus der marekschen krankheit (md) - avian herpes virus (marek's disease) - geflügel

Europäische Union - Deutsch - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologische für aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

intervet gesmbh - marek's disease virus, stamm cvi-988 (rispens), lebend -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

intervet gesmbh - marek's disease virus, stamm cvi-988 (rispens), lebend; putenherpesvirus, stamm fc-126, lebend -

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva sante animale - marek virus - konzentrat zur herstellung einer injectionssuspension - marek virus - avian herpes virus (marek's disease) - geflügel

Europäische Union - Deutsch - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologische für aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).